Open AccessEtanercept as Monotherapy in Patients with Psoriasis
Author(s) -
Craig L. Leonardi,
JEROLD L. POWERS,
Robert Matheson,
Bernard S. Goffe,
Ralph Zitnik,
Andrea Wang,
Alice B. Gottlieb
Publication year - 2003
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa030409
Subject(s) - etanercept , medicine , psoriasis , tumor necrosis factor alpha , pathogenesis , tumor necrosis factor α , antagonist , dermatology , necrosis , immunology , receptor
Inflammatory cytokines such as tumor necrosis factor (TNF) have been implicated in the pathogenesis of psoriasis. We evaluated the safety and efficacy of etanercept, a TNF antagonist, for the treatment of plaque psoriasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom